InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong · Delayed Price · Currency is HKD 52.70
-0.30 (-0.57%)
Sep 10, 2026, 11:45 AM HKT
HKG:3696 Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 357.62 | 393.34 | 125.94 | 177.18 | 207.88 |
Trading Asset Securities | 118.25 | 53.93 | - | - | - |
Cash & Short-Term Investments | 584.82 | 447.27 | 125.94 | 177.18 | 207.88 |
Cash Growth | 175.04% | 255.14% | -28.92% | -14.77% | - |
Accounts Receivable | 4.47 | 21.28 | 0.85 | 1.08 | 4.9 |
Other Receivables | 7.74 | 3.64 | 3.84 | 3.83 | 1.43 |
Receivables | 12.21 | 24.93 | 4.69 | 4.91 | 6.32 |
Prepaid Expenses | 4.04 | 2.08 | 1.7 | 1.78 | 0.82 |
Other Current Assets | - | - | 1.07 | 4.79 | 3.73 |
Total Current Assets | 601.06 | 474.28 | 133.41 | 188.65 | 218.75 |
Property, Plant & Equipment | 11.75 | 13.17 | 9.44 | 12.79 | 14.28 |
Long-Term Investments | 5.1 | 0.72 | 0.25 | 0.41 | 1.03 |
Other Intangible Assets | 0.23 | 0.27 | 0.27 | 0.38 | 0.19 |
Other Long-Term Assets | 1.55 | 1.55 | 0.64 | 0.56 | 0.54 |
Total Assets | 619.69 | 489.98 | 144 | 202.8 | 234.79 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 11.41 | 13.62 | 18.02 | 17.82 | 19.13 |
Accrued Expenses | 11.56 | 11.92 | 12.79 | 11.64 | 7.02 |
Current Portion of Leases | 1.39 | 1.9 | 1.5 | 1.27 | 1.38 |
Current Income Taxes Payable | 0.42 | 0.29 | 0.23 | 0.23 | 0.29 |
Current Unearned Revenue | 29.39 | 2.31 | 7.08 | 42.64 | 5.21 |
Other Current Liabilities | 0.21 | 3.86 | 767.25 | 778.42 | 649.47 |
Total Current Liabilities | 69.05 | 33.89 | 806.87 | 852.03 | 682.49 |
Long-Term Leases | 3.58 | 4.06 | 1.06 | 0.93 | 1.84 |
Total Liabilities | 72.63 | 37.96 | 807.93 | 852.95 | 684.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Additional Paid-In Capital | 1,504 | 1,462 | 0.62 | 0.21 | 0.21 |
Retained Earnings | -997.34 | -1,033 | -680.56 | -663.46 | -451.82 |
Treasury Stock | - | - | -2.05 | -11.35 | -11.35 |
Comprehensive Income & Other | 40.81 | 23.3 | 18.06 | 24.44 | 13.42 |
Shareholders' Equity | 547.06 | 452.03 | -663.92 | -650.16 | -449.54 |
Total Liabilities & Equity | 619.69 | 489.98 | 144 | 202.8 | 234.79 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 19.66 | 5.96 | 2.56 | 2.19 | 3.22 |
Net Cash (Debt) | 565.16 | 441.31 | 123.38 | 174.99 | 204.66 |
Net Cash Growth | 174.77% | 257.68% | -29.49% | -14.50% | - |
Net Cash Per Share | 1.73 | 5.61 | 1.72 | 2.59 | 3.05 |
Filing Date Shares Outstanding | 575.84 | 557.42 | 77.24 | 67.57 | 67.06 |
Total Common Shares Outstanding | 575.84 | 557.42 | 77.24 | 67.57 | 67.06 |
Working Capital | 532.01 | 440.39 | -673.46 | -663.37 | -463.74 |
Book Value Per Share | 0.95 | 0.81 | -8.60 | -9.62 | -6.70 |
Tangible Book Value | 546.83 | 451.76 | -664.2 | -650.54 | -449.74 |
Tangible Book Value Per Share | 0.95 | 0.81 | -8.60 | -9.63 | -6.71 |
Machinery | - | 12.04 | 10.72 | 10.4 | 4.56 |
Construction In Progress | - | 0.73 | 0.05 | 0.09 | 4.69 |
Leasehold Improvements | - | 2.06 | 3.72 | 3.5 | 2.49 |